CASE Sends Letter to Key House Leaders Urging Passage of Innovative MARCA Legislation
June 9 ,2022 CASE today sent a letter to the Chairpersons and Ranking Members of key House committees urging...
CASE Op-ed – RealClear Health: Innovative, Pro-Patient MARCA Legislation Deserves Congressional Action
April 13, 2022 It would seem that any policy innovation that could lower healthcare costs, expand access, provide better care,...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/